{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:16:42Z","timestamp":1792167402788,"version":"4.4.0"},"reference-count":336,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"G.D.L."},{"name":"Canadian Institutes for Health Research Foundation Grant"},{"name":"Q.G.K."},{"name":"Janeway Foundation Research Grant"},{"name":"Medical Research Fund Cox Award"},{"name":"Q.S."},{"name":"Alberta Diabetes Institute"},{"name":"Helmholtz Research School for Diabetes"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The very high energy demand of the heart is primarily met by adenosine triphosphate (ATP) production from mitochondrial oxidative phosphorylation, with glycolysis providing a smaller amount of ATP production. This ATP production is markedly altered in heart failure, primarily due to a decrease in mitochondrial oxidative metabolism. Although an increase in glycolytic ATP production partly compensates for the decrease in mitochondrial ATP production, the failing heart faces an energy deficit that contributes to the severity of contractile dysfunction. The relative contribution of the different fuels for mitochondrial ATP production dramatically changes in the failing heart, which depends to a large extent on the type of heart failure. A common metabolic defect in all forms of heart failure [including heart failure with reduced ejection fraction (HFrEF), heart failure with preserved EF (HFpEF), and diabetic cardiomyopathies] is a decrease in mitochondrial oxidation of pyruvate originating from glucose (i.e. glucose oxidation). This decrease in glucose oxidation occurs regardless of whether glycolysis is increased, resulting in an uncoupling of glycolysis from glucose oxidation that can decrease cardiac efficiency. The mitochondrial oxidation of fatty acids by the heart increases or decreases, depending on the type of heart failure. For instance, in HFpEF and diabetic cardiomyopathies myocardial fatty acid oxidation increases, while in HFrEF myocardial fatty acid oxidation either decreases or remains unchanged. The oxidation of ketones (which provides the failing heart with an important energy source) also differs depending on the type of heart failure, being increased in HFrEF, and decreased in HFpEF and diabetic cardiomyopathies. The alterations in mitochondrial oxidative metabolism and glycolysis in the failing heart are due to transcriptional changes in key enzymes involved in the metabolic pathways, as well as alterations in redox state, metabolic signalling and post-translational epigenetic changes in energy metabolic enzymes. Of importance, targeting the mitochondrial energy metabolic pathways has emerged as a novel therapeutic approach to improving cardiac function and cardiac efficiency in the failing heart.<\/jats:p>","DOI":"10.1093\/cvr\/cvae231","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T23:23:37Z","timestamp":1729725817000},"page":"1996-2016","source":"Crossref","is-referenced-by-count":155,"title":["Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond"],"prefix":"10.1093","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-8123","authenticated-orcid":false,"given":"Qiuyu","family":"Sun","sequence":"first","affiliation":[{"name":"Cardiovascular Research Center, University of Alberta , Edmonton, AB T6G 2S2 ,","place":["Canada"]},{"name":"Department of Pediatrics, University of Alberta , Edmonton, AB T6G 2S2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qutuba G","family":"Karwi","sequence":"additional","affiliation":[{"name":"Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland , Saint John\u2019s, NL A1B 3V6 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Wong","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, University of Alberta , Edmonton, AB T6G 2S2 ,","place":["Canada"]},{"name":"Department of Pediatrics, University of Alberta , Edmonton, AB T6G 2S2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-0454","authenticated-orcid":false,"given":"Gary D","family":"Lopaschuk","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, University of Alberta , Edmonton, AB T6G 2S2 ,","place":["Canada"]},{"name":"Department of Pediatrics, University of Alberta , Edmonton, AB T6G 2S2 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"2024121420351932300_cvae231-B1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2024121420351932300_cvae231-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurheartj\/ehx750","article-title":"Heart failure subgroups: HFrEF, HFmrEF, and HFpEF with or without mitral regurgitation","volume":"39","author":"L\u00fcscher","year":"2018","journal-title":"Eur Heart J"},{"key":"2024121420351932300_cvae231-B3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2024121420351932300_cvae231-B4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart \u2014 an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B6","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","article-title":"Energy metabolism in heart failure","volume":"555","author":"Ventura-Clapier","year":"2004","journal-title":"J Physiol"},{"key":"2024121420351932300_cvae231-B8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexcr.2017.03.052","article-title":"The role of cardiac energy metabolism in cardiac hypertrophy and failure","volume":"360","author":"Tuomainen","year":"2017","journal-title":"Exp Cell Res"},{"key":"2024121420351932300_cvae231-B10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/CRD.0b013e318274956d","article-title":"Energy metabolism in cardiac remodeling and heart failure","volume":"21","author":"Azevedo","year":"2013","journal-title":"Cardiol Rev"},{"key":"2024121420351932300_cvae231-B11","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.2174\/138161211798357773","article-title":"Optimization of cardiac metabolism in heart failure","volume":"17:","author":"Nagoshi","year":"2011","journal-title":"Curr Pharm Des"},{"key":"2024121420351932300_cvae231-B12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0008-6363(97)00047-3","article-title":"Regulation of energy substrate metabolism in the diabetic heart","volume":"34","author":"Stanley","year":"1997","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B13","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"key":"2024121420351932300_cvae231-B14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0008-6363(96)00245-3","article-title":"Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions potential for pharmacological interventions","volume":"33:","author":"Stanley","year":"1997","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1291\/hypres.26.829","article-title":"Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism","volume":"26","author":"Iemitsu","year":"2003","journal-title":"Hypertens Res"},{"key":"2024121420351932300_cvae231-B16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.107.150417","article-title":"Cardiac energy metabolism in obesity","volume":"101","author":"Lopaschuk","year":"2007","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"2024121420351932300_cvae231-B18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.3704638","article-title":"Relation between work and phosphate metabolite in the in vivo paced mammalian heart","volume":"232","author":"Balaban","year":"1986","journal-title":"Science"},{"key":"2024121420351932300_cvae231-B19","doi-asserted-by":"crossref","first-page":"H1862","DOI":"10.1152\/ajpheart.1994.267.5.H1862","article-title":"Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism","volume":"267","author":"Collins-Nakai","year":"1994","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B20","doi-asserted-by":"crossref","first-page":"29530","DOI":"10.1074\/jbc.273.45.29530","article-title":"Regulation of energy metabolism of the heart during acute increase in heart work","volume":"273","author":"Goodwin","year":"1998","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0022-2275(20)31501-7","article-title":"Fasting-induced changes in the expression of genes controlling substrate metabolism in the rat heart","volume":"42","author":"Van der Lee","year":"2001","journal-title":"J Lipid Res"},{"key":"2024121420351932300_cvae231-B22","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1152\/ajpendo.00017.2002","article-title":"Cardiac gene expression profile and lipid accumulation in response to starvation","volume":"283","author":"Suzuki","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B23","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1016\/S0021-9258(18)92956-X","article-title":"Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts","volume":"266","author":"Saddik","year":"1991","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B24","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1172\/JCI114616","article-title":"Effects of acute hyperglycemia on myocardial glycolytic activity in humans","volume":"85","author":"Wisneski","year":"1990","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0008-6363(99)00263-1","article-title":"Cardiac fatty acid uptake and transport in health and disease","volume":"45","author":"van der Vusse","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B26","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1152\/ajpendo.00298.2002","article-title":"Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA","volume":"284","author":"Augustus","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1113\/jphysiol.2004.061473","article-title":"Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates","volume":"558:","author":"Niu","year":"2004","journal-title":"J Physiol"},{"key":"2024121420351932300_cvae231-B28","doi-asserted-by":"crossref","first-page":"25836","DOI":"10.1016\/S0021-9258(19)74465-2","article-title":"Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart","volume":"268:","author":"Saddik","year":"1993","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/JMN:16:2-3:123","article-title":"Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake","volume":"16","author":"Glatz","year":"2001","journal-title":"J Mol Neurosci"},{"key":"2024121420351932300_cvae231-B30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvn116","article-title":"Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease","volume":"79:","author":"Schwenk","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B31","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1016\/S0021-9258(17)47268-1","article-title":"Mechanism of carnitine acylcarnitine translocase-catalyzed import of acylcarnitines into mitochondria","volume":"259:","author":"Murthy","year":"1984","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system \u2014 from concept to molecular analysis","volume":"244:","author":"McGarry","year":"1997","journal-title":"Eur J Biochem"},{"key":"2024121420351932300_cvae231-B33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113:","author":"Doenst","year":"2013","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI108764","article-title":"A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis","volume":"60:","author":"Mcgarry","year":"1977","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B35","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1016\/S0021-9258(17)34693-8","article-title":"Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA","volume":"253:","author":"McGarry","year":"1978","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","article-title":"Regulation of hepatic fatty acid oxidation and ketone body production","volume":"49:","author":"McGarry","year":"1980","journal-title":"Annu Rev Biochem"},{"key":"2024121420351932300_cvae231-B37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116:","author":"Savage","year":"2006","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B38","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","article-title":"Fatty acid metabolism: target for metabolic syndrome","volume":"50:","author":"Wakil","year":"2009","journal-title":"J Lipid Res"},{"key":"2024121420351932300_cvae231-B39","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1006\/jmcc.2002.2060","article-title":"Malonyl CoA control of fatty acid oxidation in the ischemic heart","volume":"34:","author":"Dyck","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2024121420351932300_cvae231-B40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cvr\/cvn130","article-title":"The malonyl CoA axis as a potential target for treating ischaemic heart disease","volume":"79:","author":"Ussher","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation \u2014 a novel therapeutic intervention in the ischemic and failing heart","volume":"18133","author":"Jaswal","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2024121420351932300_cvae231-B42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-5793(84)81201-6","article-title":"Malonyl CoA inhibition of carnitine palmityltransferase in rat heart mitochondria","volume":"176:","author":"Paulson","year":"1984","journal-title":"FEBS Lett"},{"key":"2024121420351932300_cvae231-B43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2741\/1216","article-title":"Glucose transport in the heart","volume":"9","author":"Abel","year":"2004","journal-title":"Front Biosci"},{"key":"2024121420351932300_cvae231-B44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1218530","article-title":"Identification and functional expression of the mitochondrial pyruvate carrier","volume":"337:","author":"Herzig","year":"2012","journal-title":"Science"},{"key":"2024121420351932300_cvae231-B45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/bst0311143","article-title":"Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation","volume":"31:","author":"Holness","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"2024121420351932300_cvae231-B46","doi-asserted-by":"crossref","first-page":"H1060","DOI":"10.1152\/ajpheart.00646.2012","article-title":"Ketone body metabolism and cardiovascular disease","volume":"304:","author":"Cotter","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cardfail.2020.04.005","article-title":"Myocardial ketones metabolism in heart failure","volume":"26:","author":"Karwi","year":"2020","journal-title":"J Card Fail"},{"key":"2024121420351932300_cvae231-B48","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/cvr\/cvaa143","article-title":"Ketones can become the major fuel source for the heart but do not increase cardiac efficiency","volume":"117:","author":"Ho","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B49","doi-asserted-by":"crossref","first-page":"E1046","DOI":"10.1152\/ajpendo.00097.2018","article-title":"Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart","volume":"315:","author":"Fillmore","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370:","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"2024121420351932300_cvae231-B51","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0021-9258(18)33067-9","article-title":"Inactivation of the 2-ketoglutarate and pyruvate dehydrogenase complexes of beef heart by branched chain keto acids","volume":"258:","author":"Jackson","year":"1983","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0806-4","article-title":"Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction","volume":"18:","author":"Karwi","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2024121420351932300_cvae231-B53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00726-015-1944-y","article-title":"Chronic activation of mTOR complex 1 by branched chain amino acids and organ hypertrophy","volume":"47:","author":"Neishabouri","year":"2015","journal-title":"Amino Acids"},{"key":"2024121420351932300_cvae231-B54","doi-asserted-by":"crossref","first-page":"1013.16","DOI":"10.1096\/fasebj.26.1_supplement.1013.16","article-title":"Constitutive activation of mTOR pathway by leucine causes heart hypertrophy which can be blocked by rapamycin","volume":"26","author":"Davoodi","year":"2012","journal-title":"FASEB J"},{"key":"2024121420351932300_cvae231-B55","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-018-05362-7","article-title":"Glucose promotes cell growth by suppressing branched-chain amino acid degradation","volume":"9","author":"Shao","year":"2018","journal-title":"Nat Commun"},{"key":"2024121420351932300_cvae231-B56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17:","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"2024121420351932300_cvae231-B57","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1152\/ajpendo.00276.2003","article-title":"Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves","volume":"286:","author":"Sweatt","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B58","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.7326\/0003-4819-12-8-1233","article-title":"The chemical nature of heart failure","volume":"12:","author":"Herrmann","year":"1939","journal-title":"Ann Intern Med"},{"key":"2024121420351932300_cvae231-B59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/ajplegacy.1947.150.4.733","article-title":"On the energy-rich phosphate supply of the failing heart","volume":"150:","author":"Wollenberger","year":"1947","journal-title":"Am J Physiol"},{"key":"2024121420351932300_cvae231-B60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-195102000-00002","article-title":"Myocardial metabolism in congestive heart failure","volume":"30:","author":"Olson","year":"1951","journal-title":"Medicine"},{"key":"2024121420351932300_cvae231-B61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0021-9681(59)90172-9","article-title":"Myocardial metabolism in congestive heart failure","volume":"9","author":"Olson","year":"1959","journal-title":"J Chronic Dis"},{"key":"2024121420351932300_cvae231-B62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved? On using chemical energy to support cardiac function","volume":"95:","author":"Ingwall","year":"2004","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B63","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0735-1097(00)00870-6","article-title":"Metabolism\u2014the lost child of cardiology\u2217\u2217Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology","volume":"36:","author":"Taegtmeyer","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B64","first-page":"894","article-title":"Cardiac metabolism as a target for the treatment of heart failure","volume":"110:","author":"Taegtmeyer","year":"2004","journal-title":"Am Heart Assoc"},{"key":"2024121420351932300_cvae231-B65","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: Part I: General concepts","volume":"105:","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B66","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/01.CIR.0000012467.61045.87","article-title":"Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms","volume":"105:","author":"Young","year":"2002","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B67","doi-asserted-by":"crossref","first-page":"215re3","DOI":"10.1126\/scitranslmed.3007328","article-title":"Metabolic rates of ATP transfer through creatine kinase (CK flux) predict clinical heart failure events and death","volume":"5","author":"Bottomley","year":"2013","journal-title":"Sci Transl Med"},{"key":"2024121420351932300_cvae231-B68","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139:","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B69","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","article-title":"Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy","volume":"96:","author":"Neubauer","year":"1997","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B70","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients","volume":"139:","author":"Nielsen","year":"2019","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvt216","article-title":"Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation","volume":"101:","author":"Masoud","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B72","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/pmic.200700977","article-title":"Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats","volume":"8","author":"J\u00fcllig","year":"2008","journal-title":"Proteomics"},{"key":"2024121420351932300_cvae231-B73","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9629(15)40570-1","article-title":"Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms","volume":"318:","author":"Barger","year":"1999","journal-title":"Am J Med Sci"},{"key":"2024121420351932300_cvae231-B74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0008-6363(01)00393-5","article-title":"Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism","volume":"52:","author":"Rosenblatt-Velin","year":"2001","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B75","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.109.888479","article-title":"Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure","volume":"3","author":"Kato","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","article-title":"Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy","volume":"40:","author":"D\u00e1vila-Rom\u00e1n","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B77","doi-asserted-by":"crossref","first-page":"H3270","DOI":"10.1152\/ajpheart.00887.2007","article-title":"Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy","volume":"293:","author":"Neglia","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B78","first-page":"55","article-title":"An evaluation of myocardial fatty acid and glucose uptake using PET with [18F] fluoro-6-thia-heptadecanoic acid and [18F] FDG in patients with congestive heart failure","volume":"42:","author":"Taylor","year":"2001","journal-title":"J Nucl Med"},{"key":"2024121420351932300_cvae231-B79","doi-asserted-by":"crossref","first-page":"e7533","DOI":"10.1371\/journal.pone.0007533","article-title":"Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling","volume":"4","author":"Funada","year":"2009","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B80","doi-asserted-by":"crossref","first-page":"e004953","DOI":"10.1161\/CIRCHEARTFAILURE.118.004953","article-title":"Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling","volume":"11:","author":"Voros","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B81","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cvr\/cvs424","article-title":"Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload","volume":"97:","author":"Zhabyeyev","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B82","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","article-title":"Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00395-005-0549-0","article-title":"Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart","volume":"101:","author":"Degens","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"2024121420351932300_cvae231-B84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2024121420351932300_cvae231-B85","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis","volume":"39:","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"2024121420351932300_cvae231-B86","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/dc16-0542","article-title":"Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis","volume":"39:","author":"Mudaliar","year":"2016","journal-title":"Diabetes Care"},{"key":"2024121420351932300_cvae231-B87","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cmet.2016.07.018","article-title":"Empagliflozin\u2019s fuel hypothesis: not so soon","volume":"24:","author":"Lopaschuk","year":"2016","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B88","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","article-title":"Fatty acid oxidation enzyme gene expression is downregulated in the failing heart","volume":"94:","author":"Sack","year":"1996","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cvr\/cvs164","article-title":"In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart","volume":"95:","author":"Dodd","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B90","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","article-title":"Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency","volume":"115:","author":"Ho","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B91","doi-asserted-by":"crossref","first-page":"H742","DOI":"10.1152\/ajpheart.1994.267.2.H742","article-title":"Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts","volume":"267:","author":"Allard","year":"1994","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B92","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacbts.2016.06.009","article-title":"Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning","volume":"1","author":"Diakos","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"2024121420351932300_cvae231-B93","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCRESAHA.111.243964","article-title":"PGC-1\u03b2 deficiency accelerates the transition to heart failure in pressure overload hypertrophy","volume":"109:","author":"Riehle","year":"2011","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B94","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfs192","article-title":"Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart","volume":"15:","author":"Schroeder","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2024121420351932300_cvae231-B95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvv101","article-title":"In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy","volume":"106:","author":"Seymour","year":"2015","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B96","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/CIRCIMAGING.114.001857","article-title":"Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy","volume":"7","author":"Dodd","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2024121420351932300_cvae231-B97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jacbts.2019.02.003","article-title":"Malonyl CoA decarboxylase inhibition improves cardiac function post-myocardial infarction","volume":"4","author":"Wang","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2024121420351932300_cvae231-B98","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0026-0495(94)90241-0","article-title":"Total-body and myocardial substrate oxidation in congestive heart failure","volume":"43:","author":"Paolisso","year":"1994","journal-title":"Metabolism"},{"key":"2024121420351932300_cvae231-B99","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/01.CIR.0000023531.22727.C1","article-title":"Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-\u03b1 in pacing-induced heart failure","volume":"106:","author":"Osorio","year":"2002","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B100","doi-asserted-by":"crossref","first-page":"H946","DOI":"10.1152\/ajpheart.00363.2008","article-title":"Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice","volume":"295:","author":"Sidhu","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B101","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s42255-020-00288-1","article-title":"Mitochondrial pyruvate carriers are required for myocardial stress adaptation","volume":"2","author":"Zhang","year":"2020","journal-title":"Nat Metab"},{"key":"2024121420351932300_cvae231-B102","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33:","author":"Cluntun","year":"2021","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B103","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0002-9343(54)90365-4","article-title":"Metabolism of the human heart: II. Studies on fat, ketone and amino acid metabolism","volume":"16:","author":"Bing","year":"1954","journal-title":"Am J Med"},{"key":"2024121420351932300_cvae231-B104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCGENETICS.113.000404","article-title":"Mechanical unloading promotes myocardial energy recovery in human heart failure","volume":"7","author":"Gupte","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2024121420351932300_cvae231-B105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCULATIONAHA.119.044452","article-title":"The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure","volume":"142:","author":"Badolia","year":"2020","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0008-6363(99)00294-1","article-title":"Cellular calcium homeostasis during ischemia; a thermodynamic approach","volume":"45:","author":"Fiolet","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1748-1716.2006.01621.x","article-title":"Reduced pH and contractility in failing rat cardiomyocytes","volume":"188:","author":"Kemi","year":"2006","journal-title":"Acta Physiol"},{"key":"2024121420351932300_cvae231-B108","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cvr\/cvp414","article-title":"Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload","volume":"86:","author":"Doenst","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B109","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI24405","article-title":"Mitochondrial energy metabolism in heart failure: a question of balance","volume":"115:","author":"Huss","year":"2005","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B110","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/3253","article-title":"Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy","volume":"4","author":"Depre","year":"1998","journal-title":"Nat Med"},{"key":"2024121420351932300_cvae231-B111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9149(97)00804-7","article-title":"Free fatty acid kinetics and oxidation in congestive heart failure","volume":"81:","author":"Lommi","year":"1998","journal-title":"Am J Cardiol"},{"key":"2024121420351932300_cvae231-B112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2796.2006.01663.x","article-title":"Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure","volume":"260:","author":"N\u00f8rrelund","year":"2006","journal-title":"J Intern Med"},{"key":"2024121420351932300_cvae231-B113","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cardfail.2006.06.005","article-title":"Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction","volume":"12:","author":"Tuunanen","year":"2006","journal-title":"J Card Fail"},{"key":"2024121420351932300_cvae231-B114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11886-008-0024-2","article-title":"Myocardial fatty acid metabolism and cardiac performance in heart failure","volume":"10:","author":"Tuunanen","year":"2008","journal-title":"Curr Cardiol Rep"},{"key":"2024121420351932300_cvae231-B115","doi-asserted-by":"crossref","first-page":"H842","DOI":"10.1152\/ajpheart.00455.2016","article-title":"Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure","volume":"312:","author":"Sung","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvw051","article-title":"Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression","volume":"110:","author":"Byrne","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B117","doi-asserted-by":"crossref","first-page":"H2098","DOI":"10.1152\/ajpheart.00471.2008","article-title":"Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure","volume":"295:","author":"Qanud","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B118","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171:","author":"Fillmore","year":"2014","journal-title":"Br J Pharmacol"},{"key":"2024121420351932300_cvae231-B119","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414:","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"2024121420351932300_cvae231-B120","doi-asserted-by":"crossref","first-page":"155818","DOI":"10.1016\/j.metabol.2024.155818","article-title":"Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation","volume":"154:","author":"Pherwani","year":"2024","journal-title":"Metabolism"},{"key":"2024121420351932300_cvae231-B121","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvae006","article-title":"Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction","volume":"120:","author":"Sun","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B122","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.122.062166","article-title":"Retained metabolic flexibility of the failing human heart","volume":"148:","author":"Watson","year":"2023","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B123","doi-asserted-by":"crossref","first-page":"e88102","DOI":"10.1371\/journal.pone.0088102","article-title":"1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B124","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133:","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B125","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133:","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B126","doi-asserted-by":"crossref","first-page":"e124079","DOI":"10.1172\/jci.insight.124079","article-title":"The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense","volume":"4","author":"Horton","year":"2019","journal-title":"JCI Insight"},{"key":"2024121420351932300_cvae231-B127","doi-asserted-by":"crossref","first-page":"e004417","DOI":"10.1161\/CIRCHEARTFAILURE.117.004417","article-title":"Cardiac-specific Bdh1 overexpression ameliorates oxidative stress and cardiac remodeling in pressure overload-induced heart failure","volume":"10:","author":"Uchihashi","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B128","doi-asserted-by":"crossref","first-page":"158813","DOI":"10.1016\/j.bbalip.2020.158813","article-title":"Ketone metabolism in the failing heart","volume":"1865","author":"Lopaschuk","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2024121420351932300_cvae231-B129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10557-022-07320-4","article-title":"Branched-chain amino acid metabolism in the failing heart","volume":"37:","author":"Karwi","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"2024121420351932300_cvae231-B130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B131","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133:","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B132","doi-asserted-by":"crossref","first-page":"154871","DOI":"10.1016\/j.metabol.2021.154871","article-title":"Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart","volume":"124:","author":"Uddin","year":"2021","journal-title":"Metabolism"},{"key":"2024121420351932300_cvae231-B133","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B134","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.cmet.2022.09.008","article-title":"Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure","volume":"34:","author":"Murashige","year":"2022","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","article-title":"Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure","volume":"18:","author":"Uddin","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2024121420351932300_cvae231-B136","doi-asserted-by":"crossref","first-page":"e011625","DOI":"10.1161\/JAHA.118.011625","article-title":"Therapeutic effect of targeting branched-chain amino acid catabolic flux in pressure-overload induced heart failure","volume":"8","author":"Chen","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2024121420351932300_cvae231-B137","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11:","author":"Borlaug","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2024121420351932300_cvae231-B138","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024121420351932300_cvae231-B139","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355:","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B141","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIRCRESAHA.116.310119","article-title":"Why don\u2019t we have proven treatments for HFpEF?","volume":"120:","author":"Roh","year":"2017","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B142","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131:","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B143","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147:","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B144","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568:","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"2024121420351932300_cvae231-B145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria-inflammation circuit by \u03b2-hydroxybutyrate mitigates HFpEF","volume":"128:","author":"Deng","year":"2021","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B146","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ajpath.2020.04.006","article-title":"Mouse models of heart failure with preserved or reduced ejection fraction","volume":"190:","author":"Noll","year":"2020","journal-title":"Am J Pathol"},{"key":"2024121420351932300_cvae231-B147","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10741-023-10371-w","article-title":"Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF)","volume":"29:","author":"Fisher","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2024121420351932300_cvae231-B148","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41401-023-01152-0","article-title":"Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery","volume":"45:","author":"Gao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"2024121420351932300_cvae231-B149","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine models of heart failure with preserved ejection fraction: a \u201cfishing expedition\u201d","volume":"2","author":"Valero-Mu\u00f1oz","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"2024121420351932300_cvae231-B150","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","article-title":"NAD+ repletion reverses heart failure with preserved ejection fraction","volume":"128:","author":"Tong","year":"2021","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B151","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00395-023-01020-2","article-title":"Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice","volume":"119:","author":"Sun","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"2024121420351932300_cvae231-B152","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385:","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B153","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium\u2013glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65:","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"2024121420351932300_cvae231-B154","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.119.042267","article-title":"Female sex is protective in a preclinical model of heart failure with preserved ejection fraction","volume":"140:","author":"Tong","year":"2019","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B155","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: the Framingham Study","volume":"241:","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"2024121420351932300_cvae231-B156","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67:","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B157","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/35007508","article-title":"Obesity as a medical problem","volume":"404:","author":"Kopelman","year":"2000","journal-title":"Nature"},{"key":"2024121420351932300_cvae231-B158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2024121420351932300_cvae231-B159","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S000711450000088X","article-title":"Obesity, insulin resistance and diabetes \u2014 a worldwide epidemic","volume":"83:","author":"Seidell","year":"2000","journal-title":"Br J Nutr"},{"key":"2024121420351932300_cvae231-B160","first-page":"200","volume-title":"The HFpEF Obesity Phenotype: The Elephant in the Room","author":"Kitzman","year":"2016"},{"key":"2024121420351932300_cvae231-B161","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18:","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2024121420351932300_cvae231-B162","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women","volume":"109:","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B163","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.RES.61.6.853","article-title":"Metabolism of palmitate in isolated working hearts from spontaneously diabetic \u201cBB\u201d wistar rats","volume":"61","author":"Lopaschuk","year":"1987","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B164","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","article-title":"Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob\/ob mouse hearts","volume":"53:","author":"Mazumder","year":"2004","journal-title":"Diabetes"},{"key":"2024121420351932300_cvae231-B165","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","article-title":"Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity","volume":"146:","author":"Buchanan","year":"2005","journal-title":"Endocrinology"},{"key":"2024121420351932300_cvae231-B166","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/cvr\/cvu156","article-title":"Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling","volume":"103:","author":"Alrob","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B167","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","article-title":"Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity","volume":"119:","author":"Yan","year":"2009","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B168","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molmet.2015.01.005","article-title":"Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance","volume":"4","author":"Gao","year":"2015","journal-title":"Mol Metab"},{"key":"2024121420351932300_cvae231-B169","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0006-291X(76)90255-2","article-title":"Insulin's effect on glucose oxidation independent of glucose transport","volume":"71","author":"Olefsky","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"2024121420351932300_cvae231-B170","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281:","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"2024121420351932300_cvae231-B171","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.bbalip.2016.03.020","article-title":"Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes","volume":"18611","author":"Fukushima","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2024121420351932300_cvae231-B172","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.biochi.2015.10.024","article-title":"Adipocyte lipolysis and insulin resistance","volume":"125:","author":"Morigny","year":"2016","journal-title":"Biochimie"},{"key":"2024121420351932300_cvae231-B173","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/07853890701618305","article-title":"Alterations in energy metabolism in cardiomyopathies","volume":"39:","author":"Taha","year":"2007","journal-title":"Ann Med"},{"key":"2024121420351932300_cvae231-B174","doi-asserted-by":"crossref","first-page":"e0146033","DOI":"10.1371\/journal.pone.0146033","article-title":"Diabetes alters the expression and translocation of the insulin-sensitive glucose transporters 4 and 8 in the atria","volume":"10:","author":"Maria","year":"2015","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B175","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jdi.12948","article-title":"Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal-jejunal bypass","volume":"10:","author":"Huang","year":"2019","journal-title":"J Diabetes Investig"},{"key":"2024121420351932300_cvae231-B176","doi-asserted-by":"crossref","first-page":"E612","DOI":"10.1152\/ajpendo.00011.2002","article-title":"Changes in fatty acid transport and transporters are related to the severity of insulin deficiency","volume":"283:","author":"Luiken","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B177","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI16751","article-title":"Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy","volume":"111:","author":"Yagyu","year":"2003","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B178","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","article-title":"Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy","volume":"96:","author":"Chiu","year":"2005","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B179","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI10947","article-title":"A novel mouse model of lipotoxic cardiomyopathy","volume":"107:","author":"Chiu","year":"2001","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPAR\u03b1 overexpression mimics that caused by diabetes mellitus","volume":"109:","author":"Finck","year":"2002","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B181","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","article-title":"Lipotoxic heart disease in obese rats: implications for human obesity","volume":"97:","author":"Zhou","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121420351932300_cvae231-B182","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2337\/db14-1560","article-title":"Increasing pyruvate dehydrogenase flux as a treatment for diabetic cardiomyopathy: a combined 13C hyperpolarized magnetic resonance and echocardiography study","volume":"64:","author":"Le Page","year":"2015","journal-title":"Diabetes"},{"key":"2024121420351932300_cvae231-B183","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/db12-0259","article-title":"Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice","volume":"62:","author":"Keung","year":"2013","journal-title":"Diabetes"},{"key":"2024121420351932300_cvae231-B184","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1101\/gad.269894.115","article-title":"Mitochondrial biogenesis and dynamics in the developing and diseased heart","volume":"29:","author":"Dorn","year":"2015","journal-title":"Genes Dev"},{"key":"2024121420351932300_cvae231-B185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.fjc.0000432861.55968.a6","article-title":"Heart failure and mitochondrial dysfunction: the role of mitochondrial fission\/fusion abnormalities and new therapeutic strategies","volume":"63:","author":"Knowlton","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"2024121420351932300_cvae231-B186","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2014.12.011","article-title":"Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts","volume":"21:","author":"Song","year":"2015","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B187","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cvr\/cvp344","article-title":"Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure","volume":"85:","author":"Bugger","year":"2010","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B188","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.2003.045104","article-title":"Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles","volume":"551:","author":"Garnier","year":"2003","journal-title":"J Physiol"},{"key":"2024121420351932300_cvae231-B189","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","article-title":"Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha","volume":"103:","author":"Arany","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121420351932300_cvae231-B190","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jtcvs.2010.08.003","article-title":"Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression","volume":"140:","author":"Amorim","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024121420351932300_cvae231-B191","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCRESAHA.109.212753","article-title":"Defective DNA replication impairs mitochondrial biogenesis in human failing hearts","volume":"106:","author":"Karamanlidis","year":"2010","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51:","author":"Peoples","year":"2019","journal-title":"Exp Mol Med"},{"key":"2024121420351932300_cvae231-B193","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCRESAHA.116.305432","article-title":"Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases","volume":"116:","author":"Kornfeld","year":"2015","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B194","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108:","author":"Dai","year":"2011","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy","volume":"58:","author":"Dai","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B196","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients","volume":"342:","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B197","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293:","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"2024121420351932300_cvae231-B198","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-015-1254-6","article-title":"Mitophagy and heart failure","volume":"93:","author":"Shires","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"2024121420351932300_cvae231-B199","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/S0021-9258(17)34721-X","article-title":"Coenzyme A and carnitine distribution in normal and ischemic hearts","volume":"253:","author":"Idell-Wenger","year":"1978","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B200","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1042\/BCJ20180617","article-title":"Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism","volume":"476:","author":"Karwi","year":"2019","journal-title":"Biochem J"},{"key":"2024121420351932300_cvae231-B201","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1016\/S0021-9258(19)43602-8","article-title":"Regulation of fatty acid utilization in isolated perfused rat hearts","volume":"248:","author":"Oram","year":"1973","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","article-title":"Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle","volume":"36:","author":"Neely","year":"1974","journal-title":"Annu Rev Physiol"},{"key":"2024121420351932300_cvae231-B203","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"2024121420351932300_cvae231-B204","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/dom.13762","article-title":"Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity","volume":"21:","author":"Karwi","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2024121420351932300_cvae231-B205","doi-asserted-by":"crossref","first-page":"8294","DOI":"10.1016\/S0021-9258(17)34395-8","article-title":"The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes","volume":"253:","author":"McGarry","year":"1978","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B206","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/abio.2001.5349","article-title":"Assay of the concentration and 13C-isotopic enrichment of malonyl-coenzyme A by gas chromatography-mass spectrometry","volume":"298:","author":"Reszko","year":"2001","journal-title":"Anal Biochem"},{"key":"2024121420351932300_cvae231-B207","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3340233","article-title":"Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle","volume":"334:","author":"Alam","year":"1998","journal-title":"Biochem J"},{"key":"2024121420351932300_cvae231-B208","first-page":"H2122","article-title":"Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation","volume":"275:","author":"Dyck","year":"1998","journal-title":"Am J Physiol"},{"key":"2024121420351932300_cvae231-B209","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/bj2950061","article-title":"Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation","volume":"295:","author":"Awan","year":"1993","journal-title":"Biochem J"},{"key":"2024121420351932300_cvae231-B210","first-page":"E772","article-title":"Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation","volume":"277:","author":"Goodwin","year":"1999","journal-title":"Am J Physiol"},{"key":"2024121420351932300_cvae231-B211","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1042\/bj20031565","article-title":"Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level","volume":"378:","author":"Lee","year":"2004","journal-title":"Biochem J"},{"key":"2024121420351932300_cvae231-B212","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/CIRCULATIONAHA.106.642009","article-title":"Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury","volume":"114:","author":"Dyck","year":"2006","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B213","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1161\/01.RES.0000129255.19569.8f","article-title":"Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation","volume":"94:","author":"Dyck","year":"2004","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B214","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1152\/ajpendo.2001.280.3.E471","article-title":"Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids","volume":"280:","author":"Young","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/ars.2017.7415","article-title":"Mitochondrial NAD+\/NADH redox state and diabetic cardiomyopathy","volume":"30:","author":"Berthiaume","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"2024121420351932300_cvae231-B216","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ redox balance as a therapy for heart failure","volume":"134:","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B217","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","article-title":"Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes","volume":"105:","author":"Hsu","year":"2009","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B218","doi-asserted-by":"crossref","first-page":"723996","DOI":"10.3389\/fcvm.2021.723996","article-title":"Post-translational acetylation control of cardiac energy metabolism","volume":"8","author":"Ketema","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024121420351932300_cvae231-B219","doi-asserted-by":"crossref","first-page":"e98972","DOI":"10.1371\/journal.pone.0098972","article-title":"Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion","volume":"9","author":"Yamamoto","year":"2014","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/fcp.12016","article-title":"Exogenous NAD(+) supplementation protects H9c2 cardiac myoblasts against hypoxia\/reoxygenation injury via Sirt1-p53 pathway","volume":"28:","author":"Liu","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"2024121420351932300_cvae231-B221","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10741-008-9114-x","article-title":"PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure","volume":"15:","author":"Mistry","year":"2010","journal-title":"Heart Fail Rev"},{"key":"2024121420351932300_cvae231-B222","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1152\/physiolgenomics.90296.2008","article-title":"Transcriptomic analysis of PPAR\u03b1-dependent alterations during cardiac hypertrophy","volume":"36:","author":"Smeets","year":"2008","journal-title":"Physiol Genomics"},{"key":"2024121420351932300_cvae231-B223","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.RES.0000141774.29937.e3","article-title":"Nuclear receptor signaling and cardiac energetics","volume":"95:","author":"Huss","year":"2004","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B224","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.54.9.2514","article-title":"Cardiac-specific overexpression of peroxisome proliferator-activated receptor-\u03b1 causes insulin resistance in heart and liver","volume":"54:","author":"Park","year":"2005","journal-title":"Diabetes"},{"key":"2024121420351932300_cvae231-B225","doi-asserted-by":"crossref","first-page":"H87","DOI":"10.1152\/ajpheart.00285.2005","article-title":"Chronic activation of PPAR\u03b1 is detrimental to cardiac recovery after ischemia","volume":"290:","author":"Sambandam","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B226","doi-asserted-by":"crossref","first-page":"44390","DOI":"10.1074\/jbc.M103826200","article-title":"Reactivation of peroxisome proliferator-activated receptor \u03b1 is associated with contractile dysfunction in hypertrophied rat heart","volume":"276:","author":"Young","year":"2001","journal-title":"J Biol Chem"},{"key":"2024121420351932300_cvae231-B227","doi-asserted-by":"crossref","first-page":"H305","DOI":"10.1152\/ajpheart.00553.2016","article-title":"Activation of PPAR-\u03b1 in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure","volume":"312:","author":"Kaimoto","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B228","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCHEARTFAILURE.115.002216","article-title":"Peroxisome proliferator activated receptor-\u03b1 association with silent information regulator 1 suppresses cardiac fatty acid metabolism in the failing heart","volume":"8","author":"Oka","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B229","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cmet.2011.10.001","article-title":"PPAR\u03b1-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway","volume":"14:","author":"Oka","year":"2011","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B230","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI10268","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis","volume":"106:","author":"Lehman","year":"2000","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B231","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.0000117088.36577.EB","article-title":"Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner","volume":"94:","author":"Russell","year":"2004","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B232","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Transcriptional coactivator PGC-1\u03b1 controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B233","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol"},{"key":"2024121420351932300_cvae231-B234","doi-asserted-by":"crossref","first-page":"664626","DOI":"10.3389\/fcvm.2021.664626","article-title":"Cardiac fibroblast-specific knockout of PGC-1\u03b1 accelerates AngII-induced cardiac remodeling","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024121420351932300_cvae231-B235","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/ars.2009.2940","article-title":"PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload","volume":"13:","author":"Lu","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"2024121420351932300_cvae231-B236","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCGENETICS.110.957571","article-title":"Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure","volume":"4","author":"Barth","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2024121420351932300_cvae231-B237","doi-asserted-by":"crossref","first-page":"e108201","DOI":"10.1371\/journal.pone.0108201","article-title":"Cardiac-specific inhibition of kinase activity in calcium\/calmodulin-dependent protein kinase kinase-\u03b2 leads to accelerated left ventricular remodeling and heart failure after transverse aortic constriction in mice","volume":"9","author":"Watanabe","year":"2014","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B238","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2016.11.010","article-title":"Cobalamin and folate protect mitochondrial and contractile functions in a murine model of cardiac pressure overload","volume":"102:","author":"Piquereau","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"2024121420351932300_cvae231-B239","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCHEARTFAILURE.108.812099","article-title":"Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II","volume":"2","author":"Garnier","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B240","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.06.035","article-title":"Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies","volume":"50:","author":"Sebastiani","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B241","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.111.174128","article-title":"AMP activated protein kinase-\u03b12 regulates expression of estrogen-related receptor-\u03b1, a metabolic transcription factor related to heart failure development","volume":"58:","author":"Hu","year":"2011","journal-title":"Hypertension"},{"key":"2024121420351932300_cvae231-B242","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yjmcc.2008.10.025","article-title":"PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart","volume":"46:","author":"Sihag","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"2024121420351932300_cvae231-B243","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbamcr.2012.08.015","article-title":"Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart","volume":"18333","author":"Aubert","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2024121420351932300_cvae231-B244","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1128\/MCB.24.20.9079-9091.2004","article-title":"Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle","volume":"24:","author":"Huss","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2024121420351932300_cvae231-B245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCULATIONAHA.123.066542","article-title":"Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function","volume":"149:","author":"Xu","year":"2024","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B246","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76:","author":"Semenza","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"2024121420351932300_cvae231-B247","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbadis.2018.09.024","article-title":"Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease","volume":"18655","author":"da Luz Sousa Fialho","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2024121420351932300_cvae231-B248","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B249","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1096\/fj.201500094R","article-title":"On the pivotal role of PPAR\u03b1 in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury","volume":"30:","author":"Cole","year":"2016","journal-title":"FASEB J"},{"key":"2024121420351932300_cvae231-B250","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fphys.2018.01094","article-title":"Acetylation of mitochondrial proteins in the heart: the role of SIRT3","volume":"9","author":"Parodi-Rull\u00e1n","year":"2018","journal-title":"Front Physiol"},{"key":"2024121420351932300_cvae231-B251","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.molcel.2013.12.026","article-title":"Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex","volume":"53:","author":"Fan","year":"2014","journal-title":"Mol Cell"},{"key":"2024121420351932300_cvae231-B252","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4","volume":"304:","author":"Mori","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B253","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.117.030486","article-title":"MicroRNA-195 regulates metabolism in failing myocardium via alterations in sirtuin 3 expression and mitochondrial protein acetylation","volume":"137:","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B254","doi-asserted-by":"crossref","first-page":"e0118909","DOI":"10.1371\/journal.pone.0118909","article-title":"Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD","volume":"10:","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B255","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbadis.2011.11.016","article-title":"Non-histone lysine acetylated proteins in heart failure","volume":"18222","author":"Grillon","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2024121420351932300_cvae231-B256","doi-asserted-by":"crossref","first-page":"813272","DOI":"10.3389\/fphar.2022.813272","article-title":"Honokiol inhibits atrial metabolic remodeling in atrial fibrillation through sirt3 pathway","volume":"13:","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2024121420351932300_cvae231-B257","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvy217","article-title":"Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway","volume":"115:","author":"Xu","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B258","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128:","author":"Zhou","year":"2018","journal-title":"J Clin Invest"},{"key":"2024121420351932300_cvae231-B259","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.celrep.2019.01.057","article-title":"Respiratory phenomics across multiple models of protein hyperacylation in cardiac mitochondria reveals a marginal impact on bioenergetics","volume":"26:","author":"Fisher-Wellman","year":"2019","journal-title":"Cell Rep"},{"key":"2024121420351932300_cvae231-B260","doi-asserted-by":"crossref","first-page":"H347","DOI":"10.1152\/ajpheart.00900.2015","article-title":"Acetylation and succinylation contribute to maturational alterations in energy metabolism in the newborn heart","volume":"311:","author":"Fukushima","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B261","doi-asserted-by":"crossref","first-page":"5876841","DOI":"10.1155\/2021\/5876841","article-title":"SIRT5-related desuccinylation modification contributes to quercetin-induced protection against heart failure and high-glucose-prompted cardiomyocytes injured through regulation of mitochondrial quality surveillance","volume":"20211","author":"Chang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2024121420351932300_cvae231-B262","doi-asserted-by":"crossref","first-page":"e2203628119","DOI":"10.1073\/pnas.2203628119","article-title":"Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure","volume":"119:","author":"Takada","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121420351932300_cvae231-B263","doi-asserted-by":"crossref","first-page":"104667","DOI":"10.1016\/j.jprot.2022.104667","article-title":"Global profiling of protein lysine malonylation in mouse cardiac hypertrophy","volume":"266:","author":"Wu","year":"2022","journal-title":"J Proteomics"},{"key":"2024121420351932300_cvae231-B264","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2014.03.014","article-title":"Lysine glutarylation is a protein posttranslational modification regulated by SIRT5","volume":"19:","author":"Tan","year":"2014","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B265","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.119.043319","article-title":"Increasing fatty acid oxidation prevents high-fat diet\u2013induced cardiomyopathy through regulating Parkin-mediated mitophagy","volume":"142:","author":"Shao","year":"2020","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B266","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","article-title":"Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy","volume":"111:","author":"Kolwicz","year":"2012","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B267","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/hrt.2011.226332","article-title":"Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure","volume":"97:","author":"Fragasso","year":"2011","journal-title":"Heart"},{"key":"2024121420351932300_cvae231-B268","first-page":"619","article-title":"Inhibition of fatty acid oxidation enables heart regeneration in adult mice","volume":"622:","author":"Li","year":"2023","journal-title":"Nature"},{"key":"2024121420351932300_cvae231-B269","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2006.03.060","article-title":"A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure","volume":"48:","author":"Fragasso","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B270","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment","volume":"112:","author":"Lee","year":"2005","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B271","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97:","author":"Gao","year":"2011","journal-title":"Heart"},{"key":"2024121420351932300_cvae231-B272","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/cs0990027","article-title":"First clinical trial with etomoxir in patients with chronic congestive heart failure","volume":"99:","author":"Schmidt-Schweda","year":"2000","journal-title":"Clin Sci"},{"key":"2024121420351932300_cvae231-B273","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20060307","article-title":"A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study","volume":"113:","author":"Holubarsch","year":"2007","journal-title":"Clin Sci"},{"key":"2024121420351932300_cvae231-B274","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijcard.2014.10.149","article-title":"The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials","volume":"177:","author":"Peng","year":"2014","journal-title":"Int J Cardiol"},{"key":"2024121420351932300_cvae231-B275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90:","author":"Lopaschuk","year":"2010","journal-title":"Physiol Reviol Rev"},{"key":"2024121420351932300_cvae231-B276","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.93.1.135","article-title":"Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts","volume":"93:","author":"McCormack","year":"1996","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B277","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/ecr.2022.10","article-title":"Efficacy of ranolazine to improve diastolic performance in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"18:","author":"Putri","year":"2023","journal-title":"Eur Cardiol"},{"key":"2024121420351932300_cvae231-B278","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvv105","article-title":"Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models","volume":"106:","author":"Abdurrachim","year":"2015","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B279","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-1227-8_16","volume-title":"Cardiac Energy Metabolism in Health and Disease","author":"Yan","year":"2014"},{"key":"2024121420351932300_cvae231-B280","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/cvr\/cvx045","article-title":"Inhibition of sarcolemmal FAT\/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia\/reoxygenation","volume":"113:","author":"Mansor","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B281","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9149(88)91306-9","article-title":"Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease","volume":"61:","author":"Wargovich","year":"1988","journal-title":"Am J Cardiol"},{"key":"2024121420351932300_cvae231-B282","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0735-1097(94)90665-3","article-title":"Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate","volume":"23:","author":"Bersin","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B283","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0735-1097(00)00856-1","article-title":"Dichloroacetate improves postischemic function of hypertrophied rat hearts","volume":"36:","author":"Wambolt","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2024121420351932300_cvae231-B284","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/CIRCULATIONAHA.110.011387","article-title":"Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study","volume":"123:","author":"Atherton","year":"2011","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B285","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1038\/s41598-020-65098-7","article-title":"Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure","volume":"10:","author":"B\u00f8gh","year":"2020","journal-title":"Sci Rep"},{"key":"2024121420351932300_cvae231-B286","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s42255-020-00276-5","article-title":"Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy","volume":"2","author":"Fernandez-Caggiano","year":"2020","journal-title":"Nat Metab"},{"key":"2024121420351932300_cvae231-B287","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s42255-020-00296-1","article-title":"Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice","volume":"2","author":"McCommis","year":"2020","journal-title":"Nat Metab"},{"key":"2024121420351932300_cvae231-B288","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/cvr\/cvae092","article-title":"The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure","volume":"120:","author":"Ho","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B289","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","article-title":"Ketones and the cardiovascular system","volume":"2","author":"Lopaschuk","year":"2023","journal-title":"Nat Cardiovasc"},{"key":"2024121420351932300_cvae231-B290","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1096\/fasebj.9.8.7768357","article-title":"Insulin, ketone bodies, and mitochondrial energy transduction","volume":"9","author":"Sato","year":"1995","journal-title":"FASEB J"},{"key":"2024121420351932300_cvae231-B291","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.tem.2021.07.006","article-title":"Ketone bodies for the failing heart: fuels that can fix the engine?","volume":"32:","author":"Yurista","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B292","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ejcn.2013.116","article-title":"Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets","volume":"67:","author":"Paoli","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"2024121420351932300_cvae231-B293","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1017\/S0007114513000548","article-title":"Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials","volume":"110:","author":"Bueno","year":"2013","journal-title":"Br J Nutr"},{"key":"2024121420351932300_cvae231-B294","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","article-title":"Fuel metabolism in starvation","volume":"26:","author":"Cahill","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"2024121420351932300_cvae231-B295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/dmr.5610050304","article-title":"Ketone body production and disposal: effects of fasting, diabetes, and exercise","volume":"5","author":"Balasse","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"2024121420351932300_cvae231-B296","doi-asserted-by":"crossref","first-page":"eaay8329","DOI":"10.1126\/scitranslmed.aay8329","article-title":"Elevated plasma \u03b2-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy","volume":"12:","author":"Song","year":"2020","journal-title":"Sci Transl Med"},{"key":"2024121420351932300_cvae231-B297","first-page":"H751","volume-title":"Why the Diabetic Heart is Energy Inefficient: A Ketogenesis and Ketolysis Perspective","author":"Mishra","year":"2021"},{"key":"2024121420351932300_cvae231-B298","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3945\/ajcn.110.002758","article-title":"A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects","volume":"93:","author":"Holloway","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"2024121420351932300_cvae231-B299","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/cvr\/cvaa298","article-title":"Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure","volume":"117:","author":"Nakamura","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2024121420351932300_cvae231-B300","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s42255-020-00296-1","article-title":"Nutritional modulation of heart failure in mitochondrial pyruvate carrier\u2013deficient mice","volume":"2","author":"McCommis","year":"2020","journal-title":"Nat Metab"},{"key":"2024121420351932300_cvae231-B301","first-page":"4253651","article-title":"Alternate-day ketogenic diet feeding protects against heart failure through preservation of ketogenesis in the liver","volume":"20222","author":"Guo","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"2024121420351932300_cvae231-B302","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41392-020-00411-4","article-title":"Ketogenic diets inhibit mitochondrial biogenesis and induce cardiac fibrosis","volume":"6","author":"Xu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2024121420351932300_cvae231-B303","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1749-6632.2009.04704.x","article-title":"A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes: potential protective role against apoptosis-induced heart failure","volume":"11711","author":"Balietti","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"2024121420351932300_cvae231-B304","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","article-title":"Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate","volume":"63:","author":"Clarke","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"2024121420351932300_cvae231-B305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","article-title":"Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects","volume":"63:","author":"Clarke","year":"2012","journal-title":"Regul Toxicol Pharmacol"},{"key":"2024121420351932300_cvae231-B306","doi-asserted-by":"crossref","first-page":"e007684","DOI":"10.1161\/CIRCHEARTFAILURE.120.007684","article-title":"Ketone ester treatment improves cardiac function and reduces pathologic remodeling in preclinical models of heart failure","volume":"14:","author":"Yurista","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B307","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.echo.2021.10.017","article-title":"Acute echocardiographic effects of exogenous ketone administration in healthy participants","volume":"35:","author":"Selvaraj","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"2024121420351932300_cvae231-B308","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373:","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B309","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381:","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B310","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.118.034222","article-title":"Canagliflozin and heart failure in type 2 diabetes mellitus: results from the CANVAS program","volume":"138:","author":"R\u00e5dholm","year":"2018","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B311","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2024121420351932300_cvae231-B312","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMcibr1506573","article-title":"Type 2 diabetes, SGLT2 inhibitors, and glucose secretion","volume":"373:","author":"Hattersley","year":"2015","journal-title":"N Engl J Med"},{"key":"2024121420351932300_cvae231-B313","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2024121420351932300_cvae231-B314","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21:","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"2024121420351932300_cvae231-B315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11010-006-9303-7","article-title":"Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K","volume":"296:","author":"Pelletier","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"2024121420351932300_cvae231-B316","doi-asserted-by":"crossref","first-page":"E1205","DOI":"10.1152\/ajpendo.2001.281.6.E1205","article-title":"Chronic exposure to \u03b2-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes","volume":"281:","author":"Tardif","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B317","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2013.10.036","article-title":"Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization","volume":"232:","author":"Bhattacharya","year":"2014","journal-title":"Atherosclerosis"},{"key":"2024121420351932300_cvae231-B318","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","volume":"3","author":"Shah","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"2024121420351932300_cvae231-B319","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease","volume":"163:","author":"Shah","year":"2012","journal-title":"Am Heart J"},{"key":"2024121420351932300_cvae231-B320","doi-asserted-by":"crossref","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","article-title":"Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction","volume":"311:","author":"Wang","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024121420351932300_cvae231-B321","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","article-title":"Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury","volume":"25:","author":"Li","year":"2017","journal-title":"Cell Metab"},{"key":"2024121420351932300_cvae231-B322","doi-asserted-by":"crossref","first-page":"AMP125","DOI":"10.1161\/res.127.suppl_1.MP125","article-title":"Abstract MP125: branched-chain keto acids, not branched-chain amino acids, impairs cardiac insulin sensitivity by disrupting insulin signaling in the mitochondria","volume":"127:","author":"Karwi","year":"2020","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B323","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1152\/ajpendo.00334.2019","article-title":"Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats","volume":"318:","author":"McGarrah","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024121420351932300_cvae231-B324","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.123.001791","article-title":"Obesity is a major determinant of impaired cardiac energy metabolism in heart failure with preserved ejection fraction","volume":"388:","author":"Guven","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"2024121420351932300_cvae231-B325","doi-asserted-by":"crossref","first-page":"636267","DOI":"10.3389\/fendo.2021.636267","article-title":"Aldose reductase: an emerging target for development of interventions for diabetic cardiovascular complications","volume":"12:","author":"Jannapureddy","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024121420351932300_cvae231-B326","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diab.46.2.292","article-title":"Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury","volume":"46:","author":"Ramasamy","year":"1997","journal-title":"Diabetes"},{"key":"2024121420351932300_cvae231-B327","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1096\/fj.03-1400com","article-title":"Central role for aldose reductase pathway in myocardial ischemic injury","volume":"18:","author":"Hwang","year":"2004","journal-title":"FASEB J"},{"key":"2024121420351932300_cvae231-B328","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-023-01811-w","article-title":"Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation","volume":"22:","author":"Gopal","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2024121420351932300_cvae231-B329","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.111.255216","article-title":"Redox signaling in cardiac physiology and pathology","volume":"111:","author":"Burgoyne","year":"2012","journal-title":"Circ Res"},{"key":"2024121420351932300_cvae231-B330","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.yjmcc.2006.05.003","article-title":"Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart","volume":"41:","author":"Gupte","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2024121420351932300_cvae231-B331","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/CIRCHEARTFAILURE.112.969576","article-title":"Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure","volume":"6","author":"Hecker","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2024121420351932300_cvae231-B332","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2009.04.012","article-title":"Cardioprotection of salidroside from ischemia\/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins","volume":"613:","author":"Wu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"2024121420351932300_cvae231-B333","doi-asserted-by":"crossref","first-page":"e18417","DOI":"10.1371\/journal.pone.0018417","article-title":"Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation","volume":"6","author":"Laczy","year":"2011","journal-title":"PLoS One"},{"key":"2024121420351932300_cvae231-B334","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2012.11.008","article-title":"Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway","volume":"55:","author":"Lauzier","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"2024121420351932300_cvae231-B335","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.051911","article-title":"Excessive O-GlcNAcylation causes heart failure and sudden death","volume":"143:","author":"Umapathi","year":"2021","journal-title":"Circulation"},{"key":"2024121420351932300_cvae231-B336","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.117.031942","article-title":"O-GlcNAcylation of histone deacetylase 4 protects the diabetic heart from failure","volume":"140","author":"Kronlage","year":"2019","journal-title":"Circulation"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae231\/60430251\/cvae231.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/16\/1996\/61177235\/cvae231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/16\/1996\/61177235\/cvae231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T15:37:12Z","timestamp":1734190632000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/16\/1996\/7841919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":336,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,10,25]]},"published-print":{"date-parts":[[2024,12,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae231","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,10,25]]}}}